symbol,statement_type,period_end,line_item,value
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-45290000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,0.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-2263000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,End Cash Position,6976000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,3627000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,3349000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,48639000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,528000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-40255000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,0.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,0.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,88366000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,88366000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-2263000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,0.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,0.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-2263000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,-43027000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-13900000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-115308000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,69120000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,3253000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Payable,91132000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-130935000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-157215000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,40255000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,1287000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation,1287000.0
MONOPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,44629000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-89469000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,122868000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-1751000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,End Cash Position,3627000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,4177000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-550000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,83184000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-30829000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,122868000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,122868000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-8855000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-8855000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,3984000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,1000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,5734000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,5734000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-1751000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,-87718000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-7300000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-144661000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,18415000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-4100000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Payable,29256000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-96064000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-90808000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,30829000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,1152000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,19000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation,1152000.0
MONOPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,32260000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-286169000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,-2658000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,123686000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-8630000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,End Cash Position,4177000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,0.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,4177000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,296080000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,13000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-7710000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,123686000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,-2658000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,123686000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,180104000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,196768000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,180104000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-14364000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-5734000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-5734000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-8630000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,-277539000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-1991000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-295017000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,236675000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-7932000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Payable,67760000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-326861000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-272244000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,7710000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,474000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation,474000.0
MONOPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,9296000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,2257000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,2290000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-140000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,End Cash Position,2447000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,1732000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,716000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-1541000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-7421000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,2290000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,2290000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,3590000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-1692000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,5282000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-140000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,0.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,0.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-140000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,2397000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-758000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-10856000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-179000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,302000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Payable,20913000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-5732000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-26380000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,7421000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,1082000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation,1082000.0
MONOPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,5509000.0
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,-5992000.0
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,0.0
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation,
MONOPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
